Nymox Pharmaceutical Corporation NYMX

$ 0.2 -19.68%

Annual report 2022
added 12-21-2024

Nymox Pharmaceutical Corporation Financial Statements 2011-2024 | NYMX

Annual Financial Statements Nymox Pharmaceutical Corporation

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	143 M	193 M	197 M	131 M	170 M	136 M	86.4 M	13.7 M	195 M	221 M	261 M
Shares	-	82 M	73.8 M	68.8 M	60.5 M	52.6 M	46.2 M	37.4 M	35.3 M	34.1 M	33.2 M	32.7 M
Historical Prices	0.2	1.75	2.61	2.86	2.17	3.23	3.54	2.75	0.64	5.45	5.83	7.91
Net Income	-	-12.5 M	-11.7 M	-13.2 M	-10.6 M	-13.4 M	-13.1 M	-17.9 M	-4.59 M	-4.91 M	-7.63 M	-9.65 M
Revenue	-	-	5 K	116 K	299 K	224 K	284 K	2.76 M	2.95 M	3.36 M	3.07 M	3.11 M
Cost of Revenue	-	-	4 K	58 K	138 K	149 K	173 K	160 K	-	-	-	-
Gross Profit	-	-	1 K	58 K	161 K	75 K	111 K	2.6 M	2.78 M	2.87 M	2.82 M	2.82 M
Operating Income	-	-12.5 M	-11.7 M	-13.3 M	-10.6 M	-13.2 M	-12.9 M	-17.7 M	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-12.5 M	-11.7 M	-13.3 M	-10.6 M	-13.2 M	-12.9 M	-17.7 M	-4.72 M	-4.88 M	-7.58 M	-9.61 M
Operating Expenses	-	-	11.7 M	13.4 M	10.8 M	13.3 M	13 M	20.3 M	7.5 M	7.76 M	10.4 M	12.4 M
General and Administrative Expenses	-	5.85 M	3.6 M	6.01 M	4.12 M	5.43 M	6.18 M	11.6 M	2.82 M	1.76 M	1.97 M	2.83 M

All numbers in USD currency

Quarterly Income Statement Nymox Pharmaceutical Corporation

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	86 M	-	83.8 M	81.5 M	78 M	-	74.7 M	71.7 M	71.6 M	-	70 M	68.4 M	67 M	-	61.5 M	59.3 M	57.1 M	-	53.3 M	51.5 K	49.7 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-5.09 M	-	-3.3 M	-3.99 M	-2.44 M	-	-4.16 M	-2.94 M	-2.62 M	-	-2.46 M	-5.14 M	-2.87 M	-	-2.79 M	-2.42 M	-2.66 M	-	-	-	-2.81 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	5 K	-	39 K	20 K	30 K	-	40 K	88 K	152 K	-	31 K	9 K	78 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	4 K	-	16 K	7 K	29 K	-	25 K	24 K	59 K	-	33 K	27 K	45 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-3.29 M	-3.98 M	-2.43 M	-	-4.14 M	-2.93 M	-2.63 M	-	-2.51 M	-5.2 M	-2.91 M	-	-2.81 M	-2.42 M	-2.66 M	-	-4.57 M	-2.6 M	-2.76 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-3.29 M	-3.98 M	-2.43 M	-	-4.14 M	-2.93 M	-2.63 M	-	-2.51 M	-5.2 M	-2.91 M	-	-2.81 M	-2.42 M	-2.66 M	-	-4.57 M	-2.6 M	-2.76 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	5.07 M	-	-	-	2.43 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	740 K	-	1.46 M	1.91 M	1 M	-	909 K	773 K	1.08 M	-	1.02 M	2.88 M	1.18 M	-	1.17 M	935 K	794 K	-	-	7 K	1.12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency